The Involvement of the JAK-STAT Signaling Pathway in Chronic Inflammatory Skin Disease Atopic Dermatitis

Overview

Journal JAKSTAT

Date 2013 Sep 27

PMID 24069552

Citations 110

Authors

Lei Bao

Huayi Zhang

Lawrence S Chan

Affiliations

Soon will be listed here.

Abstract

Atopic dermatitis (AD), a common chronic inflammatory skin disease, is characterized by inflammatory cell skin infiltration. The JAK-STAT pathway has been shown to play an essential role in the dysregulation of immune responses in AD, including the exaggeration of Th2 cell response, the activation of eosinophils, the maturation of B cells, and the suppression of regulatory T cells (Tregs). In addition, the JAK-STAT pathway, activated by IL-4, also plays a critical role in the pathogenesis of AD by upregulating epidermal chemokines, pro-inflammatroy cytokines, and pro-angiogenic factors as well as by downregulating antimicrobial peptides (AMPs) and factors responsible for skin barrier function. In this review, we will highlight the recent advances in our understanding of the JAK-STAT pathway in the pathogenesis of AD.

Citing Articles

Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis.

Liao Q, Pan H, Guo Y, Lan Y, Huang Z, Wu P PLoS One. 2025; 20(2):e0319400.

PMID: 39992967 PMC: 11849894. DOI: 10.1371/journal.pone.0319400.

STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis.

Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B Bioimpacts. 2025; 15:30030.

PMID: 39963570 PMC: 11830145. DOI: 10.34172/bi.30030.

Exosomes and Exosome-Mimetics for Atopic Dermatitis Therapy.

Kim J, Kim J, Kang S, Yoon J Tissue Eng Regen Med. 2025; .

PMID: 39832066 DOI: 10.1007/s13770-024-00695-5.

Regulatory effects of extract and Diphlorethohydroxycarmalol on skin barrier function.

Bak S, Lim H, Won Y, Park S, Cheong S, Lee S Heliyon. 2024; 10(23):e40227.

PMID: 39654745 PMC: 11625274. DOI: 10.1016/j.heliyon.2024.e40227.

Topical delivery of baricitinib-impregnated nanoemulgel: a promising platform for inhibition of JAK -STAT pathway for the effective management of atopic dermatitis.

Nene S, Devabattula G, Vambhurkar G, Tryphena K, Khatri D, Godugu C Drug Deliv Transl Res. 2024; .

PMID: 39467941 DOI: 10.1007/s13346-024-01732-5.

References

Owczarek W, Paplinska M, Targowski T, Jahnz-Rozyk K, Paluchowska E, Kucharczyk A . Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis. Cytokine. 2010; 50(2):181-5. DOI: 10.1016/j.cyto.2010.02.016. View

Wolf R, Wolf D . Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol. 2012; 30(3):329-34. DOI: 10.1016/j.clindermatol.2011.08.023. View

OShea J, Lahesmaa R, Vahedi G, Laurence A, Kanno Y . Genomic views of STAT function in CD4+ T helper cell differentiation. Nat Rev Immunol. 2011; 11(4):239-50. PMC: 3070307. DOI: 10.1038/nri2958. View

Chapoval S, Dasgupta P, Dorsey N, Keegan A . Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukoc Biol. 2010; 87(6):1011-8. PMC: 2872539. DOI: 10.1189/jlb.1209772. View

Minegishi Y, Karasuyama H . Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol. 2008; 21(2):105-12. DOI: 10.1093/intimm/dxn134. View

OShea J, Plenge R . JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012; 36(4):542-50. PMC: 3499974. DOI: 10.1016/j.immuni.2012.03.014. View

Horr B, Borck H, Thurmond R, Grosch S, Diel F . STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. Int Immunopharmacol. 2006; 6(10):1577-85. DOI: 10.1016/j.intimp.2006.06.005. View

Dillon S, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell S . Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004; 5(7):752-60. DOI: 10.1038/ni1084. View

Jiang H, Harris M, Rothman P . IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol. 2000; 105(6 Pt 1):1063-70. DOI: 10.1067/mai.2000.107604. View

10.

Esche C, Benedetto A, Beck L . Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep. 2004; 4(4):276-84. DOI: 10.1007/s11882-004-0071-8. View

11.

Howell M, Kim B, Gao P, Grant A, Boguniewicz M, DeBenedetto A . Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007; 120(1):150-5. PMC: 2669594. DOI: 10.1016/j.jaci.2007.04.031. View

12.

Goenka S, Kaplan M . Transcriptional regulation by STAT6. Immunol Res. 2011; 50(1):87-96. PMC: 3107597. DOI: 10.1007/s12026-011-8205-2. View

13.

He R, Kim H, Yoon J, Oyoshi M, MacGinnitie A, Goya S . Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol. 2009; 124(4):761-70.e1. PMC: 2895457. DOI: 10.1016/j.jaci.2009.07.040. View

14.

Guttman-Yassky E, Nograles K, Krueger J . Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol. 2011; 127(6):1420-32. DOI: 10.1016/j.jaci.2011.01.054. View

15.

Kasraie S, Niebuhr M, Baumert K, Werfel T . Functional effects of interleukin 31 in human primary keratinocytes. Allergy. 2011; 66(7):845-52. DOI: 10.1111/j.1398-9995.2011.02545.x. View

16.

Chen L, Lin S, Overbergh L, Mathieu C, Chan L . The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE. Clin Exp Immunol. 2005; 142(1):21-30. PMC: 1809492. DOI: 10.1111/j.1365-2249.2005.02894.x. View

17.

Brandt C, Pavlovic V, Radbruch A, Worm M, Baumgrass R . Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy. 2009; 64(11):1588-96. DOI: 10.1111/j.1398-9995.2009.02054.x. View

18.

Shimoda K, van Deursen J, Sangster M, Sarawar S, Carson R, Tripp R . Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 1996; 380(6575):630-3. DOI: 10.1038/380630a0. View

19.

Hayashida S, Uchi H, Moroi Y, Furue M . Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. J Dermatol Sci. 2011; 61(3):180-6. DOI: 10.1016/j.jdermsci.2010.10.013. View

20.

Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar B, Chan L . Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol. 2004; 138(3):375-87. PMC: 1809236. DOI: 10.1111/j.1365-2249.2004.02649.x. View